Search
for
Sort by
Research 841–870 of 1000+
- Dupilumab for alopecia areata treatment: A double‐edged sword?
- Treatment of Lichen Planopilaris With Abrocitinib
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Pathomechanisms of immune-mediated alopecia
- Ruxolitinib for the treatment of severe alopecia areata
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Parsing patterns: Emerging roles of tissue self-organization in health and disease
- Novedades terapéuticas en tricología
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
- Alopecia Areata: Clinical Treatment
- Hair Follicle Reconstruction and Stem Cells
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- The role of janus kinases in the treatment of autoimmune skin diseases
- Efficacy of tofacitinib in pediatric alopecia universalis
- Deucravacitinib in dermatology: current indication and existing off-label data
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.